The Th2 cytokines IL-4 and IL-13 also seem to play a role in asthmatic inflammation [1], but therapies targeting IL-5 [19–21], IL-4 [72], or IL-13 [73, 74] have provided little or no relief of asthma symptoms and little relief from airways hyperresponsiveness. This evidence concerns the gene IL4 and asthma.